Implantable cardioverter defibrillators vs beta‐blocker
Non‐fatal cardiovascular events · people with cardiac channelopathies
Implantable cardioverter defibrillators may leads to higher non‐fatal cardiovascular events compared with β‐blocker therapy (low certainty).
1 finding from 1 review
- Implantable defibrillators versus medical therapy for cardiac channelopathies 2015 · Cochrane Headline outcomes onlyRR 11.44 [1.57, 83.36]2 studies · 86 participantsLow